天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> journal list >> ACS Applied Materials & Interfaces >>article
ACS Applied Materials & Interfaces

ACS Applied Materials & Interfaces

IF: 8.3
Download PDF

Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.

Published:16 February 2021 DOI: 10.3389/fimmu.2021.614704 PMID: 33664745
Camille Keenan, Kim E Nichols, Sabrin Albeituni

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory syndrome driven by overactive T cells and macrophages that abundantly secrete numerous pro-inflammatory cytokines, including interferon (IFN)-gamma, interleukin (IL)-1-beta, IL-2, IL-6, IL-10, IL-18, and tumor necrosis factor (TNF). The release of these and other cytokines underlies many of the clinical and pathologic manifestations of HLH, which if left untreated, can lead to multi-organ failure and death. The advent of etoposide-based regimens, such as the Histiocyte Society HLH-94 and HLH-2004 protocols, has substantially decreased the mortality associated with HLH. Nevertheless, the 5-year survival remains low at ~60%. To improve upon these results, studies have focused on the use of novel cytokine-directed therapies to dampen inflammation in HLH. Among the agents being tested is ruxolitinib, a potent inhibitor of the Janus Kinase (JAK) and Signal Transducer and Activation of Transcription (STAT) pathway, which functions downstream of many HLH-associated cytokines. Here, we review the basic biology of HLH, including the role of cytokines in disease pathogenesis, and discuss the use of ruxolitinib in the treatment of HLH.

Substances (9)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Etoposide 33419-42-0 C29H32O13 603 suppliers $9.00-$16790.00
Ruxolitinib 941678-49-5 C17H18N6 399 suppliers $25.00-$2757.40
Acid Red 94 632-69-9 C20H5Cl4I4NaO5 345 suppliers $10.00-$869.00
HUMAN IL-2 110942-02-4 61 suppliers $110.00-$1510.00
MOUSE IL-10 45 suppliers Inquiry
IL-18 41 suppliers Inquiry
MOUSE IL-6 37 suppliers $75.00-$591.00
Interleukin (IL)-6 Receptor C??H??N??O?? 18 suppliers Inquiry
Interferon-g (IFN-g) 4 suppliers Inquiry

Similar articles

IF:0

Teneligliptin: DPP-4 inhibitor in the treatment of type II Diabetes Mellitus

International Journal of Phytopharmacy K. Danao, M. Shende,etc Published: 30 August 2017
IF:13

Gatifloxacin: a review of its use in the treatment of bacterial infections in the US.

Drugs Susan J Keam, Katherine F Croom,etc Published: 1 January 2005
IF:4.3

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

ACS Applied Electronic Materials Noemi Lois, Evie Gardner,etc Published: 14 July 2020